- Delaying treatment for localised prostate cancer does not increase mortality risk, trial shows 13 March 2023 Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind today. The latest findings from the ProtecT trial, led by the Universities of Oxford and Bristol, are presented today at the European Association of Urology (EAU) Congress in Milan and published in the New England Journal of Medicine.
- Working together to fight cancer 27 January 2023 On 25 January 2023 the Bristol Cancer Research Network invited 17 researchers and clinicians to present on projects that are looking to prevent, detect and treat cancer - by working with someone outside their own field of expertise. These collaborations are expected to, or are already providing, real-world applications to combat this dreadful disease.
- Patient-specific cancer tumours replicated in 3D bioprinting advance 2 November 2022 Bowel cancer patients could in future benefit from a new 3D bioprinting technology which would use their own cells to replicate the complex cellular environment of solid tumours in 3D models. The University of Bristol-led advance, published in Biofabrication, would allow clinicians to treat the models, known as spheroids, with chemotherapy drugs and radiation to help them understand an individual patient’s resistance to therapies.
- Films explain how we can find solutions for a healthier future 1 November 2022 Climate change is one of the biggest health threats facing humanity. It is already affecting our health, and these impacts are likely to increase. A series of short films developed by the University of Bristol’s Elizabeth Blackwell Institute for Health Research and Cabot Institute for the Environment explain how the health of our planet is linked to human health, and how research at Bristol will help us to understand these complex and interwoven issues.
- Reprogramming of immune cells shown to fight off melanoma 31 October 2022 A new way of reprogramming our immune cells to shrink or kill off cancer cells has been shown to work in the otherwise hard to treat and devastating skin cancer, melanoma. The University of Bristol-led discovery, published in Advanced Science today [31 October], demonstrates a new way to clear early stage pre-cancerous and even late-stage tumour cells.
- Boosting physical activity/curbing sitting time highly likely to lower breast cancer risk 6 September 2022 Boosting physical activity levels and curbing sitting time are highly likely to lower breast cancer risk, finds research designed to strengthen proof of causation. The study led by Cancer Council Victoria in Australia, and including the Bristol Medical School: Population Health Sciences, is published online today [6 September] in the British Journal of Sports Medicine.
- Prof Carmen Galán receives the SRUK/CERU Merit Award 2022 17 August 2022 The Society of Spanish Researchers in the United Kingdom (SRUK/CERU) announced that Prof Carmen Galán, Professor Organic and Biological Chemistry at the University of Bristol, is the winner of the SRUK/CERU Merit Award 2022 for her prolific and outstanding scientific career both in Spain and in the UK.
- Mathematical modelling could lead to simple blood test for brain tumours 3 August 2022 University of Bristol research could lead to better detection of the most common type of malignant brain cancer.
- Scientists discover genes that affect the risk of developing pre-leukaemia 14 July 2022 The discovery of 14 inherited genetic changes which significantly increase the risk of a person developing a symptomless blood disorder associated with the onset of some types of cancer and heart disease is published today [July 14] in Nature Genetics. The finding, made in one of the largest studies of its kind through genetic data analysis on 421,738 people, could pave the way for potential new approaches for the prevention and early detection of cancers including leukaemia.
- The Bristol Cancer Research Network's Early Career Researchers' symposium 27 June 2022 The University of Bristol's Cancer Research Network, supported by the Elizabeth Blackwell Institute, hosted its first symposium dedicated to early career researchers in the Life Sciences Building on 24 June 2022. Jointly hosted with the National Institute for Health and Care Research (NIHR) Clinical Research Network (CRN) West of England, the event showcased the extraordinary and diverse research being conducted by postgraduate students, postdoctoral researchers, clinical fellows and trainees.
Cancer research press releases
Press releases relating to cancer research on the University's central news pages.